Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220447) titled 'L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance' on Oct. 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: City of Hope Medical Center
Condition:
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Intervention:
Other: Survey Administration
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: December 21, 2025
Target Sample Size: 50
Countries of Recruitment:
United States
To know more, visit...